1 Potential & Actual Opioid Diversion in Vietnam, Methods of Preventing Diversion, and Barriers to “Balance” Eric Krakauer, MD, PhD Harvard Medical School.

Slides:



Advertisements
Similar presentations
Cindy Powers Magrini, PharmD, BCPS
Advertisements

RATIONAL USE OF INJECTION: An Integrated Tool For Monitoring Injection Prescription in the Kingdom of CAMBODIA Dr Sok Srun Department of Hospitals, MoH.
Chapter 17: Institutional Pharmacy Jeffery D. Evans, Pharm.D. Associate Professor of Pharmacy Practice.
Improved Retrospective Drug Utilization Review for Potential Opioid Overutilizers — Results from the Pilot CMS 2012 Medicare Advantage & Prescription Drug.
CDER/CSS ALSDAC September 9-10, 2003 Risk Management and the Controlled Substances Act: The FDA Perspective Deborah B. Leiderman, M.D., M.A. Director Controlled.
Improving Quality, Addressing Disparities, and Achieving Equity Language Barriers and Health Care Joseph R. Betancourt, M.D., M.P.H. Director, The Disparities.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
1 District of Columbia Medical Assistance Administration Expedited Prior Authorization Pharmacy Guidance NOTE: As of October 1, 2008, the Medical Assistance.
MaineCare & Opioid Treatment Where we are… How we got here… Where we are going… Kevin S. Flanigan, MD Medical Director Office of MaineCare Services.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
Situation analysis in Kyrgyzstan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
FDA REMS Program REMS: Risk Evaluation & Management Strategy
Drug Diversion, Sources, and Extent: United States Case Study Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist Pain & Policy Studies.
Contents of the presentation OST programme in SA region - Current scenario Scaling up OST in SA region Supply chain management.
March года Barcelona, Spain Tajikistan country presentation.
Research Activities to Document Progress During IPPF Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist Pain & Policy Studies Group.
Designing a drug control system that balances access with prevention and control of misuse: What should it look like? Martha Maurer, MSSW, MPH, PhD Pain.
Ukraine:Palliative care development Brasov, Romania October 25-28, 2011 Украина: Развитие паллиативной помощи Брашов, Румыния октября 2011 года.
Concerns About Addiction: Bringing Clarity to Confusion about Addiction Terminology Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist.
Country Report for: UKRAINE Natallia Datsiuk, MPH Bogomolets National Medical University Ukraine, Kyiv.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
For Pain or Not for Pain: Methadone Madness
Current System of Drug Control In Georgia Prof. D. Kordzaia – Georgian National Association for Palliative Care VIENNA - March 5-6, 2013 “Making Oral Opioids.
“Improving opioid availability through advocacy” Experience from Serbia Snežana Bošnjak International Pain Policy Fellow ( ) Institute for Oncology.
Ministry of Health of the Republic of Armenia Feb 2013.
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
Overviews of the Drug Distribution System & Barriers to Opioid Availability Dr. Bishnu Dutta Paudel International Pain Policy Fellowship Training Program.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Description of the current system of drug control in Romania Prof. Daniela Mosoiu, MD, PhD Hospice Casa Sperantei Brasov, Romania.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Country Report for:
Medicines and Service Availability and Accessibility in Cancer Care in Georgia 28 th August 2012 Tbilisi Tamari Rukhadze MD. PhD. Oncologist, International.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Tajikistan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
Meg O’Brien, Ph.D. Director, Global Access to Pain Relief Initiative Procurement & Manufacture of IR Oral Morphine: Uganda experience 1.
“” “Balance” Jim Cleary, MD Associate Professor of Medicine Director, Palliative Care Medicine, UW Hospital & Clinics Director, WHO Collaborating Center.
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
An International Comparison of Healthcare and Pharmacy Practice Jason Milton, Pharm.D. Candidate College of Pharmacy University of Georgia June 02, 2006.
Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
"Perspectives of former International Pain Policy Fellows" Prof. Snežana Bošnjak, MD, PhD Institute for Oncology and Radiology of Serbia (IORS) Belgrade,
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs.
The Heroin Epidemic in rural Maryland Rural Health Learning Collaboration Sept. 28, 2015 James A. Cockey, MD, FACP Deputy Health Officer.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
Background: Tomson G 1, Kronvall G 2, Chuc NTK 3, Binh NT 4, Chalker J 5, Falkenberg T 1. 1 Div. International Health (IHCAR), Dep. Public Health Sciencies,
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Drug diversion & palliative care Indian perspective 2/22/2016
Methadone Maintenance System Performance Measures – 2011/2012 Office of the Provincial Health Officer January 28, Dr. Eric Young, MD, MHSc, CCFP,
Accessibility, Pattern of Use and Implications of Restricted Availability of Medicines for Treatment of Substance Abuse in a Tertiary Level Health Care.
دکترارتین کمالی ثابتی ( متخصص پزشکی قانونی ومسمومیتها )
Training guide Recording and handling of Schedule 8 drugs in hospital wards ( including healthcare services and other patient care settings)
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
A Global Policy Approach to Opioid Drug Availability
Medication Assisted Treatment
Current Concepts in Pain Management
Legal and Regulatory Issues in Pain Management
XVI International AIDS Conference
THE OPIOID CRISIS Mississippi Board of Nursing
American Public Health Association Annual Meeting November 5, 2007
Medication-Assisted Therapy at Coleman Profession Services
Federal Regulations requirements for opioid prescription course
Indispensable, adequately provided and not unduly restricted
Opioids in Butte County
Opioid Use Disorders: Recognition and Pharmacotherapy Review
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Dr. Mark Levine, Commissioner of Health
Medication Assisted Treatment of Opioid Use Disorder
Situation analysis in Kyrgyzstan
Presentation transcript:

1 Potential & Actual Opioid Diversion in Vietnam, Methods of Preventing Diversion, and Barriers to “Balance” Eric Krakauer, MD, PhD Harvard Medical School Center for Palliative Care Massachusetts General Hospital Copyright © 2012 Eric L. Krakauer & Massachusetts General Hospital. All rights reserved.

2 Outline Background: Opioid use & abuse in Vietnam: past & present –Vietnamese opiophobia Prevention of diversion –Laws & regulations –Discretionary control of opioid prescribing by healthcare leaders Evidence of diversion of controlled medicines Ways forward

3 History of Opioids in Vietnam … Opium trade controlled by French colonial regime in 19 th & early 20 th centuries –Major source of revenue –Means of social control –”Village quotas” Opium trafficking by CIA 1950 – 1970s as means of financing clandestine operations & war (Laos) Heroin use by US & ARVN soldiers Current epidemic of injected heroin dependence driving Vietnam’s HIV/AIDS epidemic

4 Illicit opioid use – now mainly injected heroin – is a major problem in Vietnam: ~170,000 IDU

5 …History of Opioids in Vietnam Results: –Profound cultural OPIOPHOBIA. Association of opioids with Western tyranny and “social evils.” –Negative language about opioids throughout Vietnamese law. –Strict regulatory control of opioid prescribing: Limits on prescribers: –Right to prescribe, dose, duration –Reluctance / refusal by healthcare leaders to permit staff to prescribe opioids Limits on pharmacists

6 Opioid Availability in Vietnam: Progress through partnerships and policy reform Before 2008 –Max Rx period 7 days –Max Rx 30 mg/5 days –No CA/AIDS=no opioid –Records 5 years –Insuff IR morphine –Limited pt access –No guidelines –Inadequate PC training –Hospital directors decide who can Rx Starting in 2008 –30 days –No max dose –No CA/AIDS=7 day Rx –2 years –Increased domestic mfg –District avail. plan –MoH PC guidelines –MoH PC Train Program –Hospital directors still decide who can Rx

7 Recent Evidence of Diversion of Controlled Medicines 2000: 2 nurses at National Cancer Hospital (Hanoi) sentenced to 2 years in prison for collecting ~100 dispensed but unused vials of diazepam, selling it to private pharmacies. 2006: 2 pharmacists from Kien Giang Province sentenced to 7 years in prison for stealing ketamine & selling it to interested individuals. No confirmed reports of opioid diversion.

8 Results of Diversion of Controlled Medicines Changes in regulatory policy:  Diazepam briefly classified as “narcotic:”  Very secure storage  Restrictions on prescribing that limited access (It is now considered again a psychotropic drug with less strict regulations for storage and prescribing.) Prison terms for all diverters Probably greater fear among MDs that they will be held responsible if a patient diverts.  At HCMC Cancer Hospital, rumor of a patient’s family selling morphine –> Hospital Director reduced maximum outpatient opioid prescription length to 5 days.

9 Ways Forward Toward Balance Avoid unnecessarily risky practices –Eg.: Stocking morphine at HIV OPCs with no pharmacist. MoH certification in pain relief & pc –Certified MDs should be able to prescribe opioids –At least 1 – 2 MDs certified in pc at each district hospital Oral IR morphine available in all districts as planned. Scale-up palliative home care – health insurance must cover home care. Opioid contracts required for patients with risk factors for “dependence syndrome” or diversion. Routine monitoring: –Of opioid consumption –For diversion (models?)